CB Insights
Technology Market Intelligence
Technology Market Intelligence
6 Dimensions Capital (通和毓承), formed from the merger of Frontline BioVentures and WuXi Healthcare Ventures, is a healthcare-focused investment firm.
Phone: +86 (021) 5046-2227
Suite 1106, Building A, SCG Parkside, 868 Lane, Yinghua Road
Pudong New District
Shanghai, 201204
Shanghai, China
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-11-13 | Kymera Therapeutics | Series B | $65M | AJU IB Investment, Bessemer Venture Partners, Hatteras Venture Partners, MRL Ventures, Pfizer Venture Investments, and Sanofi Ventures |
| 2018-09-05 | Fulcrum Therapeutics | Series B | $80M | Casdin Capital, Fidelity Investments, Foresite Capital, Leerink Partners, NS Investment, Sanofi Ventures, and Section 32 |
| 2018-08-06 | Zhiguang Technology | Unattributed VC | ||
| 2018-08-01 | GloriousMed | Series A | $11M | Shiyu Capital |
| 2018-07-27 | Curon Biopharmaceutical | Series A | $150M | Boyu Capital (博裕资本), and Temasek Holdings |
